Vertex Pharmaceuticals Change in Accounts Payable 2010-2025 | VRTX
Vertex Pharmaceuticals change in accounts payable for the twelve months ending March 31, 2025 was $0.092B, a 54.24% decline year-over-year.
- Vertex Pharmaceuticals annual change in accounts payable for 2024 was $0.05B, a 1.64% increase from 2023.
- Vertex Pharmaceuticals annual change in accounts payable for 2023 was $0.049B, a 59.69% decline from 2022.
- Vertex Pharmaceuticals annual change in accounts payable for 2022 was $0.121B, a 278.68% increase from 2021.